Skip to main content
. 2021 Mar 5;29(4):529–539.e3. doi: 10.1016/j.chom.2021.03.002

Table 1.

Neutralization of variants by mAbs

Virus Valuea mAbs
B38 COVA1-18 COVA2-15 DH1041 DH1042 DH1043 DH1047 H4 P2B-2F6 S309
D614G IC50 2.10 0.0060 0.0058 0.0094 0.011 0.0081 0.14 2.10 0.071 0.048
IC80 12.00 0.031 0.028 0.036 0.068 0.040 0.54 18.00 1.20 0.69
D614G.B117 IC50 30 (14.2x) 0.011 (1.8x) 0.05 (8.7x) 0.015 (1.6x) 0.052 (4.7x) 0.01 (1.3x) 0.17 (1.2x) 9.9 (4.7x) 0.075 (1.1x) 9.2 (191.4x)
IC80 >50 (> 4x) 0.16 (5.1x) 0.95 (34.5x) 0.039 (1.1x) 0.13 (1.9x) 0.05 (1.3x) 0.64 (1.2x) >50 (> 3x) 2.2 (1.8x) >50 (> 72x)
D614G.N501Y IC50 4.7 (2.2x) 0.032 (5.2x) 0.084 (14.6x) 0.01 (1.1x) 0.012 (1.1x) 0.015 (1.8x) 0.072 (0.5x) 3.7 (1.7x) 0.043 (0.6x) 0.15 (3.1x)
IC80 >50 (> 4x) 0.19 (6.1x) 0.93 (33.8x) 0.034 (1x) 0.06 (0.9x) 0.058 (1.5x) 0.43 (0.8x) 46 (2.5x) 0.93 (0.8x) >50 (> 72x)
D614G.del69-70 IC50 1.5 (0.7x) 0.0042 (0.7x) 0.0051 (0.9x) 0.007 (0.8x) 0.0095 (0.9x) 0.0077 (0.9x) 0.1 (0.7x) 2.5 (1.2x) 0.1 (1.4x) 0.018 (0.4x)
IC80 9.9 (0.8x) 0.026 (0.8x) 0.026 (0.9x) 0.029 (0.8x) 0.053 (0.8x) 0.033 (0.8x) 0.5 (0.9x) 26 (1.4x) 1.1 (0.8x) 18 (26.8x)
D614G.del69-70.N501Y IC50 2.5 (1.2x) 0.026 (4.3x) 0.051 (8.8x) 0.0044 (0.5x) 0.0061 (0.6x) 0.0074 (0.9x) 0.049 (0.4x) 3.1 (1.5x) 0.033 (0.5x) 0.11 (2.2x)
IC80 40 (3.3x) 0.18 (5.8x) 11.6 (56.4x) 0.025 (0.7x) 0.039 (0.6x) 0.035 (0.9x) 0.28 (0.5x) 30 (1.6x) 1.0 (0.8x) >50 (> 72x)
D614G.del69-70.Y453F IC50 1.2 (0.5x) 0.0083 (1.4x) 0.0055 (0.9x) 0.0046 (0.5x) 0.004 (0.4x) 0.011 (1.4x) 0.048 (0.3x) 0.64 (0.3x) 0.094 (1.3x) 0.098 (2x)
IC80 15 (1.3x) 0.043 (1.4x) 0.03 (1.1x) 0.027 (0.8x) 0.03 (0.5x) 0.05 (1.3x) 0.24 (0.4x) 5.7 (0.3x) 1.3 (1x) 11 (15.5x)
D614G.N439K IC50 1.3 (0.6x) 0.0061 (1x) 0.011 (1.9x) 0.0075 (0.8x) 0.0063 (0.6x) 0.017 (2.1x) 0.016 (0.1x) 3.6 (1.7x) 0.15 (2.2x) 0.046 (0.9x)
IC80 19 (1.6x) 0.049 (1.6x) 0.1 (3.8x) 0.035 (1x) 0.07 (1x) 0.059 (1.5x) 0.33 (0.6x) 42 (2.3x) 1.6 (1.3x) 0.38 (0.6x)

Numbers in parentheses followed by “x” represent fold differences over D614G. NA signifies data not available. >3-fold increase in IC50 or IC80 concentration over D614G represents moderate decrease in susceptibility. >10-fold increase in IC50 or IC80 concentration over D614G represents substantial decrease in susceptibility. <0.33-fold of the IC50 or IC80 of D614G represents moderate increase in susceptibility.

a

Unit of IC50 and IC80 concentrations is μg/mL.